Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC) - Episode 1

Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro

,

Panelists discuss how lung large cell neuroendocrine carcinoma (LCNEC) is characterized by its biology, incidence, risk factors, clinical presentation, and prognosis, while addressing the challenges, unmet needs, and the trial data required to guide testing and treatment guidelines for this rare cancer.

Now Viewing
EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro
EP. 2: An Overview of the Molecular Characterization of Lung LCNEC
EP. 3: The Pathological Diagnosis of Lung LCNEC
EP. 4: Biomarker Testing Strategies for Lung LCNEC
EP. 5: Biopsy Best Practices: Diagnosing Lung LCNEC
EP. 6: Lung LCNEC Diagnostic Challenges
EP. 7: A Multidisciplinary Approach to Managing Lung LCNEC
EP. 8: Lung LCNEC Disease Histology and Prognosis
EP. 9: The Role of DLL3 in LCNEC of the Lung
EP. 10: Insights on the LANCE Pilot Study on Lung LCNEC
  1. Dr. Dietrich to provide a brief overview of lung LCNEC:
  • Biology
  • Incidence
  • Risk factors
  • Presentation
  • Prognosis
  1. Dr. Yang to Dr. Dietrich:
  • How often do you see these patients in your practice?
  • What challenges and unmet needs surround lung LCNEC?
  • What trial data are needed to inform development of guidelines around LCNEC testing and treatment?

Related Content:

Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC)
Insights on the LANCE Pilot Study on Lung LCNEC
The Role of DLL3 in LCNEC of the Lung
Lung LCNEC Disease Histology and Prognosis